| Andre Dwayne Miller, MD | |
|
1120 15th St, Augusta, GA 30912-0004 | |
| (706) 721-2273 | |
| Not Available |
| Full Name | Andre Dwayne Miller |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 1120 15th St, Augusta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922413913 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 6890 (Georgia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Med Now Urgent Care, Llc | 5799835153 | 8 |
News Archive
The ongoing COVID-19 pandemic is spread by respiratory aerosols, in which tiny droplets of saliva and mucus containing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are expelled from the upper respiratory tract. Though quite a few studies have investigated the viral load of such droplets, not much is known about how far these droplets move or how long they linger in the air, even though such information is crucial to determining how infectious they are.
AVANIR Pharmaceuticals, Inc. today announced efficacy, safety and tolerability results from the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of patients with pseudobulbar affect (PBA).
A recent FDA approval supported by Stand Up To Cancer research provides a new treatment option for patients with an aggressive form of prostate cancer.
Today's headlines include reports about mini-med plans and accountable care organizations as well as the ongoing impasse in Congress regarding current year spending.
› Verified 5 days ago
| Entity Name | Au Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841230620 PECOS PAC ID: 9931013513 Enrollment ID: O20040107000188 |
News Archive
The ongoing COVID-19 pandemic is spread by respiratory aerosols, in which tiny droplets of saliva and mucus containing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are expelled from the upper respiratory tract. Though quite a few studies have investigated the viral load of such droplets, not much is known about how far these droplets move or how long they linger in the air, even though such information is crucial to determining how infectious they are.
AVANIR Pharmaceuticals, Inc. today announced efficacy, safety and tolerability results from the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of patients with pseudobulbar affect (PBA).
A recent FDA approval supported by Stand Up To Cancer research provides a new treatment option for patients with an aggressive form of prostate cancer.
Today's headlines include reports about mini-med plans and accountable care organizations as well as the ongoing impasse in Congress regarding current year spending.
› Verified 5 days ago
| Entity Name | Med Now Urgent Care, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245475771 PECOS PAC ID: 5799835153 Enrollment ID: O20090608000055 |
News Archive
The ongoing COVID-19 pandemic is spread by respiratory aerosols, in which tiny droplets of saliva and mucus containing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are expelled from the upper respiratory tract. Though quite a few studies have investigated the viral load of such droplets, not much is known about how far these droplets move or how long they linger in the air, even though such information is crucial to determining how infectious they are.
AVANIR Pharmaceuticals, Inc. today announced efficacy, safety and tolerability results from the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of patients with pseudobulbar affect (PBA).
A recent FDA approval supported by Stand Up To Cancer research provides a new treatment option for patients with an aggressive form of prostate cancer.
Today's headlines include reports about mini-med plans and accountable care organizations as well as the ongoing impasse in Congress regarding current year spending.
› Verified 5 days ago
| Entity Name | Perfect Health Always On Call. Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457797938 PECOS PAC ID: 8426366287 Enrollment ID: O20150929001460 |
News Archive
The ongoing COVID-19 pandemic is spread by respiratory aerosols, in which tiny droplets of saliva and mucus containing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are expelled from the upper respiratory tract. Though quite a few studies have investigated the viral load of such droplets, not much is known about how far these droplets move or how long they linger in the air, even though such information is crucial to determining how infectious they are.
AVANIR Pharmaceuticals, Inc. today announced efficacy, safety and tolerability results from the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of patients with pseudobulbar affect (PBA).
A recent FDA approval supported by Stand Up To Cancer research provides a new treatment option for patients with an aggressive form of prostate cancer.
Today's headlines include reports about mini-med plans and accountable care organizations as well as the ongoing impasse in Congress regarding current year spending.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andre Dwayne Miller, MD 1120 15th St Ste Bi1056, Augusta, GA 30912-0004 Ph: (706) 721-3813 | Andre Dwayne Miller, MD 1120 15th St, Augusta, GA 30912-0004 Ph: (706) 721-2273 |
News Archive
The ongoing COVID-19 pandemic is spread by respiratory aerosols, in which tiny droplets of saliva and mucus containing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are expelled from the upper respiratory tract. Though quite a few studies have investigated the viral load of such droplets, not much is known about how far these droplets move or how long they linger in the air, even though such information is crucial to determining how infectious they are.
AVANIR Pharmaceuticals, Inc. today announced efficacy, safety and tolerability results from the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of patients with pseudobulbar affect (PBA).
A recent FDA approval supported by Stand Up To Cancer research provides a new treatment option for patients with an aggressive form of prostate cancer.
Today's headlines include reports about mini-med plans and accountable care organizations as well as the ongoing impasse in Congress regarding current year spending.
› Verified 5 days ago
Dr. Toya Hester Kelley, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-3157 | |
Dr. Daria Ravangard, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-6569 | |
Janis S. Coffin, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-4588 Fax: 706-721-7264 | |
Dr. William Robert Rout, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 963 Bennock Mill Dr., Augusta, GA 30906 Phone: 352-538-5899 | |
Racquel Puranda, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 678-790-0634 | |
Angela Overstreet Wright, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2607 Commons Blvd, Augusta, GA 30909 Phone: 706-750-8601 | |
Shahed Anam Ibn Faruk, Family Medicine Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-2273 |